Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

David R. Gandara

Has grant

Co-Director, Center for Experimental Therapeutics in Cancer

University of California Davis Comprehensive Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Recent Grants

Grant: Close

UCDCCC NCTN UG1 PROGRAM

Open Date: 2019-03-06

Close Date: 2026-02-28

Grant: Close

Targeting KRAS mutant lung cancers

Open Date: 2015-08-01

Close Date: 2020-07-31

Grant: Close

UCDCCC NCTN U10 Program

Open Date: 2014-04-14

Close Date: 2019-02-28

Grant: Close

TAS::75 0849::TAS EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS

Open Date: 2011-09-23

Close Date: 2012-09-22

Grant: Close

A system biology approach to biomarkers for early detection of lung cancer

Open Date: 2011-07-01

Close Date: 2013-06-30

Articles (20)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Collaborators (22)

David Gerber

Professor of Internal Medicine (Hematology-Oncology) and Clinical Sciences

University of Texas Southwestern Medical Center

UNITED STATES

View details

David Carbone

Ohio State University Medical Center

UNITED STATES

View details

Martin Edelman

Physician and Chair

Fox Chase Cancer Center

UNITED STATES

View details

Adam Dicker

Professor & Chair

Thomas Jefferson University

UNITED STATES

View details

Giovanni Nigita

Assistant Professor

The Ohio State University Wexner Medical Center

UNITED STATES

View details

Saiama Waqar

Professor of Medicine

Washington University in St. Louis

UNITED STATES

View details

Yara G Abdou

University of North Carolina at Chapel Hill

UNITED STATES

View details

Rebecca Boxer

University of California Davis School of Medicine

UNITED STATES

View details

surbhi singhal

Member

University of California, Davis

UNITED STATES

View details

Shiruyeh Schokrpur

Assistant Professor

University of California, Davis

UNITED STATES

View details

Eloisa Jantus Lewintre

Profesora titular

Universitat Politècnica de València

SPAIN

View details

Miles Andrews

Group Leader

MONASH UNIVERSITY

AUSTRALIA

View details

Christopher J. Sweeney

University of Adelaide

AUSTRALIA

View details

Mary Redman

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Natalie Vokes

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Philip Mack

Senior Research Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

Hossein Borghaei

Professor and Chief, Thoracic Oncology

Fox Chase Cancer Center

UNITED STATES

View details

Seema Nagpal

UNITED STATES

View details

Katie Minichiello

Fred Hutch Cancer Center

UNITED STATES

View details

Ferdinandos Skoulidis

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Neeraj Agarwal

Faculty Member

Dana-Farber Cancer Institute

UNITED STATES

View details

Aakash Desai

University of Alabama, Tuscaloosa

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David R. Gandara

Research Interests

Explore related searches

Recent Grants

Articles (20)

Resistance to Immune Checkpoint Inhibitor Treatment in Non–Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators

Review of patient‐reported outcomes in EMPOWER‐Lung 1 in patients with advanced non‐small cell lung cancer treated with cemiplimab versus chemotherapy

Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non–Small Cell Lung Cancer: A Lung-MAP Study

Older Adult Participation in Early-Phase Lung Cancer Clinical Trials, 1998 to 2020

Clinical strategies for lung cancer management: Recommendations from the Bridging the Gaps Lung Cancer Consensus Conference 2024

Role of the International Society of Liquid Biopsy (ISLB) in establishing quality control frameworks for clinical integration

Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Costs and Benefits of Whole-Exome, Whole-Transcriptome Sequencing in Patients With Advanced Non–Small Cell Lung Cancer

Fragmentomic-based algorithm to computationally predict tumor-somatic, germline, and clonal hematopoiesis variant origin in liquid biopsy

Brief Report: Safety of Pulse-Dose Osimertinib for Treatment of Leptomeningeal Disease or Refractory Brain Metastases in EGFR-Mutated Nonsmall Cell Lung Cancer.

Decoding resistance to immune checkpoint inhibitors in non-small cell lung cancer: a comprehensive analysis of plasma proteomics and therapeutic implications

Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types

International society of liquid biopsy (ISLB) perspective on minimal requirements for ctDNA testing in solid tumors.

Prognostic value of patient-reported outcomes for survival in patients with advanced lung cancer receiving immune checkpoint inhibitors.

Authors response to “Letter to the Editor”: “Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types”

Adjuvant chemotherapy for stage IA-IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial.

CGE25-111: Enhancing Oncology Treatment Personalization through Plasma Proteomics and Machine Learning.

Genetic Ancestry and Lung Cancer in Latin American Patients: A Crucial Step for Understanding a Diverse Population.

A Phase 1/1B Trial of Pembrolizumab and Trametinib in Advanced NSCLC Enriched for KRAS Mutations.

Plasma Proteome–Based Test for First-Line Treatment Selection in Metastatic Non–Small Cell Lung Cancer

Collaborators (22)

David Gerber

David Carbone

Martin Edelman

Adam Dicker

Giovanni Nigita

Saiama Waqar

Yara G Abdou

Rebecca Boxer

surbhi singhal

Shiruyeh Schokrpur

Eloisa Jantus Lewintre

Miles Andrews

Christopher J. Sweeney

Mary Redman

Natalie Vokes

Philip Mack

Hossein Borghaei

Seema Nagpal

Katie Minichiello

Ferdinandos Skoulidis

Neeraj Agarwal

Aakash Desai

Make your next move.